Antianginal efficacy of omapatrilat in patients with chronic angina pectoris

American Journal of Cardiology

Volumn 95, Issue 11, 2005, Pages 1283-1289

  Chaitman, Bernard R ^a   Ivleva, Alla Y ^b   Ujda, Marek ^b   Lenis, Jacque H F ^b   Toth, Csaba ^b   Stieber, David M ^b   Reisin, Leonardo H ^b   Pangerl, Andreas M ^b   Friedman, Julie B ^b   Lawrence, John H ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; OMAPATRILAT; PLACEBO; VASOPEPTIDASE INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR SYMPTOM; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DIZZINESS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; DYSPHAGIA; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ST SEGMENT DEPRESSION; STATISTICAL SIGNIFICANCE; TREADMILL EXERCISE;

ANGINA PECTORIS; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPRILYSIN; PYRIDINES; THIAZEPINES;

EID: 21144454517     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.01.069     Document Type: Article

References (26)

1. C.C. Lang, A.M.J. Choy, A.D. Struthers Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis Clin Sci 83 1992 519 527
2. H.H. Holzgrefe, S.R. Arthur, J.R. Powell Vasopeptidase inhibition in a canine model of exercise-induced left ventricular dysfunction Clin Exp Pharmacol Physiol 29 2002 696 703
3. W.J. Remme Bradykinin-mediated cardiovascular protective actions of ACE inhibitors A new dimension in anti-ischaemic therapy? Drugs 54 suppl 5 1997 59 70
4. X.P. Yang, Y.H. Liu, E. Peterson, O.A. Carretero Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury The role of kinins J Cardiovasc Pharmacol 29 1997 250 256
5. G. Piedimonte, J.A. Nadel, C.S. Long, J.I. Hoffman Neutral endopeptidase in the heart Neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation Circ Res 75 1994 770 779
6. J.A. Schriefer, E.P. Broudy, A.H. Hassen Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model J Pharmacol Exp Ther 278 1996 1034 1039
7. N.C. Trippodo, M. Fox, V. Natarajan, B.C. Panchal, C.R. Dorso, M.M. Asaad Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure J Pharmacol Exp Ther 267 1993 108 116
8. G.F. Mitchell, J.L. Izzo, Y. Lacourciere, J.P. Ouellet, J. Neutel, C. Qian, L.J. Kerwin, A.J. Block, M.A. Pfeffer Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension; results of the Conduit Hemodynamics of Omapatrilat International Research Study Circulation 105 2002 2955 2961
9. P.Y. Marie, P.M. Mertes, N. Hassan-Sebbag, N. de Talence, K. Djaballah, W. Djaballah, J. Friberg, P. Olivier, G. Karcher, F. Zannad, A. Bertrand Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers J Am Coll Cardiol 43 2004 353 359
10. T. Quaschning, L.V. d'Uscio, S. Shaw, T.F. Luscher Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension Hypertension 37 2001 1108 1113
11. F. Regamey, M. Maillard, J. Nussberger, H.R. Brunner, M. Burmier Renal hemodynamic and natriuretic effects of angiotensin-converting enzyme and neutral endopeptidase inhibition in man Hypertension 40 2002 266 272
12. J.S.R. Gibbs, P.A. Crean, L. Mockus, C. Wright, G.C. Sutton, K.M. Fox The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina Br Heart J 62 1989 112 117
13. A.F.M. van den Heuvel, P.H.J.M. Dunselman, T. Kingma, P. Verhorst, F. Boomsma, W.H. van Gilst, D.J. van Veldhuisen Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade J Am Coll Cardiol 37 2001 470 474
14. H. Ikram, C.J. Low, T.M. Shirlaw, S.G. Foy, I.G. Crozier, A.M. Richards, N.S. Khurmi, R.J. Horsburgh Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine Br Heart J 71 1994 30 33
15. P. Thurmann, H.J. Odenthal, N. Rietbrock Converting enzyme inhibition in coronary artery disease: a randomized, placebo-controlled trial with benazepril J Cardiovasc Pharmacol 17 1991 718 723
16. B.R. Winkelmann, G. Matheis, P. Kleist, S. Potter, D. Wohltmann, M. Kaltenbach Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease Coron Artery Dis 5 1994 829 844
17. J.C. Kaski, G. Rosano, S. Gavrielides, L. Chen Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina J Am Coll Cardiol 23 1994 652 657
18. J. Simon, R. Gibbs, P.A. Crean, L. Mockus, C. Wright, G.C. Sutton, K.M. Fox The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina Br Heart J 62 1989 112 117
19. C.J. Pepine, J.L. Rouleau, K. Annis, A. Ducharme, P. Ma, J. Lenis, R. Davies, U. Thadani, B. Chaitman, H.E. Haber QUASAR Study Group Effects of angiotensin-converting enzyme inhibition of transient ischemia: the Quinapril Anti-ischemia and Symptoms of Angina Reduction (QUASAR) Trial J Am Coll Cardiol 42 2003 2049 2059
20. B. Tamesis, A. Stelken, S. Byers, L. Shaw, L. Younis, D.D. Miller, B.R. Chaitman Comparison of the Asymptomatic Cardiac Ischemia Pilot and modified Asymptomatic Cardiac Ischemia Pilot versus Bruce and Cornell exercise protocols Am J Cardiol 72 1993 715 720
21. B.R. Chaitman, P.H. Stone, G.L. Knatterud, S.A. Forman, G. Sopko, M.G. Bourassa, C. Pratt, W.J. Rogers, C.J. Pepine, C.R. Conti ACIP Investigators Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes J Am Coll Cardiol 26 1995 585 593
22. D.G. Caralis, L. Shaw, B. Bilgere, L. Younis, K. Stocke, R.D. Wiens, B.R. Chaitman Application of computerized exercise ECG digitization Interpretation in large clinical trials J Electrocardiol 25 1992 101 110
23. E.N. Allred, E.R. Bleecker, B.R. Chaitman, T.E. Dahms, S.O. Gottlieb, J.D. Hackney, M. Pagano, R.H. Selvester, S.M. Walden, J. Warren Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease N Engl J Med 321 1989 1426 1432
24. SAS/STAT User's Guide, Version 6 4th Ed 1990 SAS Institute Cary, NC: 864-877
25. J.B. Kostis, M. Packer, H.R. Black, Schmieder, D. Henry, E. Levy Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs Enalapril (OCTAVE) trial Am J Hypertens 17 2004 103 111
26. R.J. Gibbons, K. Chatterjee, J. Daley, J.S. Douglas, S.D. Fihn, J.M. Gardin, M.A. Grunwald, D. Levy, B.W. Lytle, R.A. O'Rourke ACC/AHA/ACP--ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina) J Am Coll Cardiol 33 1999 2092 2197